SNSE Latest Press Releases

-- January 7, 2026 --

Egle Therapeutics Appoints John Celebi as Chief Executive Officer Globe Newswire 8:00 AM

-- November 14, 2025 --

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:30 AM

-- October 30, 2025 --

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value Globe Newswire 9:00 AM

-- October 17, 2025 --

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 Globe Newswire 8:00 AM

-- September 23, 2025 --

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 Globe Newswire 7:30 AM

-- September 3, 2025 --

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software